Regulation of protein kinases in insulin, growth factor and Wnt signalling

Current Opinion in Structural Biology

Volumn 12, Issue 6, 2002, Pages 761-767

  Pearl, Laurence H ^a   Barford, David ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASEIN KINASE II; CELL SURFACE RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT KINASE 1; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LEF; UNCLASSIFIED DRUG; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 0036909402     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(02)00386-X     Document Type: Review

References (46)

1. Johnson L.N., Noble M.E.M., Owen D.J. Active and inactive protein kinases: structural basis for regulation. Cell. 85:1996;149-158.
2. Huse M., Kuriyan J. The conformational plasticity of protein kinases. Cell. 109:2002;275-282.
3. Fiol C.J., Haseman J.H., Wang Y.H., Roach P.J., Roeske R.W., Kowalczuk M., Depaoliroach A.A. Phosphoserine as a recognition determinant for glycogen synthase kinase-3: phosphorylation of a synthetic peptide based on the G-component of protein phosphatase-1. Arch Biochem Biophys. 267:1988;797-802.
4. Ding V.W., Chen R.H., McCormick F. Differential regulation of glycogen synthase kinase 3b by insulin and Wnt signalling. J Biol Chem. 275:2000;32475-32481.
5. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:1997;3797-3804.
6. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosscheld R., Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
7. Molenaar M., van de Wetering M., Oosterwegel M., Petersonmaduro J., Godsave S., Korinek V., Roose J., Destree O., Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 86:1996;391-399.
8. He T.-C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
9. Cross D.A.E., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
10. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851.
11. Behrens J., Jerchow B.A., Wurtele M., Grimm J., Asbrand C., Wirtz R., Kuhl M., Wedlich D., Birchmeier W. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3 beta. Science. 280:1998;596-599.
12. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3 beta and beta-catenin and promotes GSK-3 beta-dependent phosphorylation of beta-catenin. EMBO J. 17:1998;1371-1384.
13. Yamamoto H., Kishida S., Kishida M., Ikeda S., Takada S., Kikuchi A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3 beta regulates its stability. J Biol Chem. 274:1999;10681-10684.
14. Yost C., Farr G.H., Pierce S.B., Ferkey D.M., Chen M.M., Kimelman D. GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell. 93:1998;1031-1041.
15. Farr G.H., Ferkey D.M., Yost C., Pierce S.B., Weaver C., Kimelman D. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol. 148:2000;691-701.
16. Li L., Yuan H.D., Weaver C.D., Mao J.H., Farr G.H., Sussman D.J., Jonkers J., Kimelman D., Wu D.Q. Axin and Frat1 interact with DvI and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 18:1999;4233-4240.
17. Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H. Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 105:2001;721-732. The authors reveal the crystal structure of GSK3β. They also identified the binding site for phospho-primed substrates and demonstrated autoinhibition by the phosphorylated N terminus.
18. ter Haar E., Coll J.T., Austen D.A., Hsiao H.M., Swenson L., Jain J. Structure of GSK3 beta reveals a primed phosphorylation mechanism. Nat Struct Biol. 8:2001;593-596. The crystal structure of GSK3β with a bound phosphate is described.
19. Robbins D.J., Zhen E., Owaki H., Vanderbilt C.A., Ebert D., Geppert T.D., Cobb M.H. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem. 268:1993;5097-5106.
20. Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., Pettman G., Mannix C., Culbert A.A., Brown M.J.B., et al. The structure of phosphorylated GSK-3 beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure. 9:2001;1143-1152. The structural identification of the FRAT-binding site on GSK3β in the C-lobe, not the N-lobe, as had been previously suggested.
21. Frame S., Cohen P., Biondi R.M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell. 7:2001;1321-1327. The authors identify the binding site for phospho-primed substrates and demonstrate its role in the specificity and autoinhibition of GSK3β.
22. Canagarajah B.J., Khokhlatchev A., Cobb M.H., Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 90:1997;859-869.
23. Thomas G.M., Frame S., Goedert M., Nathke I., Polakis P., Cohen P. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett. 458:1999;247-251.
24. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 359:2001;1-16.
25. Liu C., Li Y., Semenov M., Han C., Baeg G.-H., Tan Y., Zhang Z., Lin X., He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 108:2002;837-847. The unequivocal demonstration that β-catenin, like GS and other insulin signalling targets, requires a priming phosphorylation for subsequent hyperphosphorylation by GSK3β. This makes it much less likely that selective inhibitors of insulin signalling by GSK3β would not also inhibit Wnt signalling and thereby be carcinogenic.
26. Yanagawa S., Matsuda Y., Lee J.-S., Matsubayashi H., Sese S., Kadowaki T., Ishimoto A. Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. EMBO J. 21:2002;1733-1742. The identification of CK1α as the priming kinase of β-catenin.
27. Cohen P. The development and therapeutic potential of protein kinase inhibitors. Curr Opin Chem Biol. 3:1999;459-465.
28. Ferkey D.M., Kimelman D. Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and axin. J Biol Chem. 277:2002;16147-16152. See annotation to [29•].
29. Fraser E., Young N., Dajani R., Franca-Koh J., Ryves J., Williams R.S.B., Yeo M., Webster M.T., Richardson C., Smalley M.J., et al. Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J Biol Chem. 277:2002;2176-2185. A mutagenesis study (see also [28•]) showing that the FRAT- and axin-binding sites on GSK3β overlap.
30. Biondi R.M., Komander D., Thomas C.C., Lizcano J.M., Deak M., Alessi D.R., van Aalten D.M.F. High resolution crystal structure of the human PDK1 catalytic domain defined the regulatory phosphopeptides docking site. EMBO J. 21:2002;4219-4228. The authors solved the crystal structure of PDK1, with an ordered phosphorylated activation segment.
31. Yang J., Cron P., Thompson V., Good V.M., Hess D., Hemmings B.A., Barford D. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol Cell. 9:2002;1227-1240. The crystal structure of PKB and mechanism of activation by HMs are described.
32. Plowman G.D., Sudarsanam S., Bingham J., Whyte D., Hunter T. The protein kinases of Caenorhabditis elegans: a model for signal transduction in multicellular organisms. Proc Natl Acad Sci USA. 96:1999;13603-13610.
33. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 26:2001;657-664.
34. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
35. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:1996;6541-6551.
36. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G.F., Holmes A.B., Gaffney P.R., Reese C.B. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science. 279:1998;710-714.
37. Stokoe D., Stephens L.R., Copeland T., Gaffney P.R., Reese C.B., Painter G.F., Holmes A.B., McCormick F., Hawkins P.T. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 277:1997;567-570.
38. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Ba. Curr Biol. 7:1997;261-269.
39. Testa J.R., Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 98:2001;10983-10985.
40. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 273:1998;13375-13378.
41. 2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24). EMBO J. 12:1993;849-859.
42. Knighton D.R., Zheng J., Ten Eyck L.F., Ashford V.A., Xuong N.-H., Taylor S.S., Sowadski J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253:1991;407-413.
43. Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C.P., Alessi D.R.C.B. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol. 9:1999;393-404.
44. Biondi R.M., Cheung P.C., Casamayor A., Deak M., Currie R.A., Alessi D.R. Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J. 19:2000;979-988.
45. Yang J, Cron P, Good VM, Thompson V, Hemmings BA, Barford D: Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat Struct Biol 2002, in press. This paper describes the detailed interactions of the HM of PKB and PIF with the N-lobe of PKB and explains the peptide substrate specificity of PKB.
46. Frodin M., Antal T.L., Dummler B.A., Jensen C.J., Deak M., Gammeltoft S., Biondi R.M. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 21:2002;5396-5407.